Specificity: Recognizes a single chain glycoprotein of 105/120kDa, identified as CD30/Ki-1. This MAb distinguishes large cell lymphomas derived from activated lymphoid cells from histiocytic malignancies and lymphomas derived from resting and precursor lymphoid cells or from anaplastic carcinomas. Immunogen: Human CD30 recombinant protein